Condition
Developmental Dysplasia of Hip
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting1
Terminated1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06647225Not ApplicableRecruitingPrimary
Using Artificial Intelligence to Screen for Hip Dysplasia
NCT07066852Enrolling By InvitationPrimary
Evaluation of the Effectiveness of Developmental Hip Dysplasia Screening in Risk Groups
NCT03275805Not ApplicableTerminatedPrimary
Should Graf IIc Hips be Treated for 12 Weeks
Showing all 3 trials